Abstract:Generation of hiPSCs with multi‐gene modifications, including motor neuron‐specific transcription factors Ngn2, Isl1, and Lhx3 controlled by Tet‐On system and one anti‐apoptosis gene Bcl‐xL. The genetically modified hiPSCs survived and directionally differentiated into motor neurons after transplantation in vivo. The genetically modified hiPSCs partially converted into neural progenitors, serving as a spare cell resource. Objectives Transplantation of neural progenitor cells (NPCs) derived from human‐induced pluripotent stem cells (hiPSCs) is one of the promising treatment strategies for motor neuron diseases (MNDs). However, the inefficiency in committed differentiation of NPCs in vivo limits its application. Here, we tried to establish a potential therapeutic strategy for MNDs by in vivo directional differentiation of hiPSCs engineered with motor neuron (MN) specific transcription factors and Tet‐On system. Materials and Methods We engineered hiPSCs with three MN‐specific transcription factors and Tet‐On system. The engineered cells were directly transplanted into immunodeficient mice through subcutaneous, intra‐spinal cord and intracerebroventricular injections. Following doxycycline (Dox) induction, teratoma formation, and motor MN differentiation were evaluated. Results We generated genetically engineered hiPSCs, in which the expression of Ngn2, Isl1, and Lhx3 was controlled by a drug‐inducible transgenic system. These cells showed normal pluripotency and proliferative capacity, and were able to directionally differentiate into mature motor neurons (MNs) and NPCs with high efficiency in spinal cords and cerebral lateral ventricles under the induction of Dox. The grafts showed long‐term survival in the recipient mice without formation of teratoma. Conclusions The induced mature MNs and NPCs were expected to replace the damaged endogenous MNs directly, and play a role of de novo stem cell stock for long‐term neuron damage repair, respectively. Therefore, in vivo directional differentiation of the hiPSCs engineered with MN‐specific transcription factors and Tet‐On system via Dox induction could be a potential therapeutic strategy for MNDs with high efficacy and safety.

Directed differentiation of functional corticospinal-like neurons from endogenous SOX6+/NG2+ cortical progenitors

Title Efficient derivation of dopaminergic neurons from SOX 1 (-) floorplate cells under defined culture conditions

Directed Differentiation of Human Hindbrain Neuroepithelial Stem Cells Recapitulates Cerebellar Granule Neurogenesis

Temporal response of neural progenitor cells to disease onset and progression in amyotrophic lateral sclerosis-like transgenic mice.

Dedifferentiation-like Reprogramming of Degenerative Nucleus Pulposus Cells into Notochordal-Like Cells by Defined Factors

Motor neuron degeneration promotes neural progenitor cell proliferation, migration, and neurogenesis in the spinal cords of amyotrophic lateral sclerosis mice.

Synchronous 3D patterning of diverse CNS progenitors generates motor neurons of broad axial identity

Conversion of Mouse Fibroblasts into Oligodendrocyte Progenitor-Like Cells Through a Chemical Approach.

Restoration of skilled locomotion by sprouting corticospinal axons induced by co-deletion of PTEN and SOCS3

Neuronal Subtype-Specific Genes that Control Corticospinal Motor Neuron Development In Vivo

A novel protocol to derive cervical motor neurons from induced pluripotent stem cells for amyotrophic lateral sclerosis

Astrocytic reprogramming combined with rehabilitation strategy improves recovery from spinal cord injury.

Neural Differentiation and spinal cord organoid generation from induced pluripotent stem cells (iPSCs) for ALS modelling and inflammatory screening

Transcription Factor-Mediated Differentiation of Motor Neurons from Human Pluripotent Stem Cells

Reprogramming Astrocytes to Motor Neurons by Activation of Endogenous Ngn2 and Isl1

Spontaneously regenerative corticospinal neurons in mice

Inducible motor neuron differentiation of human induced pluripotent stem cells in vivo

Two-Step Generation of Oligodendrocyte Progenitor Cells From Mouse Fibroblasts for Spinal Cord Injury

Selective Targeting of a Defined Subpopulation of Corticospinal Neurons using a Novel Klhl14-Cre Mouse Line Enables Molecular and Anatomical Investigations through Development into Maturity

Motoneuron Differentiation of Induced Pluripotent Stem Cells from Sod1g93a Mice

Progress and challenges in directing the differentiation of human iPSCs into spinal motor neurons